Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1993-07-02
1995-12-26
Kestler, Kimberly J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
514168, C07C40100
Patent
active
054788161
ABSTRACT:
Liquid vitamin formulation containing an ester of antirachitic vitamin D esterified at the 3 carbon position such as vitamin D.sub.3 palmitate, greater than 252 mg/ml water and at least about 100 mg/ml polyhydroxylated solvent such as glycerine. The formulations have improved taste and improved storage stability.
REFERENCES:
patent: 2758923 (1956-08-01), Wakely
D. R. Fraser and E. Kodicek, "Enzyme Studies on the Esterification of Vitamin D in Rat Tissues," Biochem. J., 109, 457-467, 1968.
W. Huber and D. W. Barlow, "Chemical and Biological Stability of Crystalline Vitamins D.sub.2 and D.sub.3 and Their Derivatives," J. Biol. Chem., 149, 125-137, 1943.
Matthew G. Silva, et al., "Reversed-Phase Liquid Chromatographic Determination of Vitamin D in Infant Formulas and Enteral Nutritionals," Journal of AOAC International, 75(3), 566-571, 1992.
Miloslav Rechcigl, Jr., Editor, Handbook of Nutritive Value of Process Food, vol. 1, "Food For Use," CRC Series in Nutrition and Food, 1982.
Bristol--Myers Squibb Company
Kestler Kimberly J.
Savitsky Thomas R.
LandOfFree
Liquid vitamin formulations containing vitamin D esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid vitamin formulations containing vitamin D esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid vitamin formulations containing vitamin D esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369277